Company QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Ratings for QuidelOrtho Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
39.69 ^USD	-2.77%		+3.74%	-46.15%

Apr. 02	QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	MT
Apr. 02	QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	MT

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Number of employees: 7,100

Managers	Title	Age	Since
Michael Iskra CEO	Chief Executive Officer	54	22-04-30
Robert Bujarski PSD	President	55	05-06-30
Joseph Busky DFI	Director of Finance/CFO	56	-
Louise Brandy CTO	Chief Tech/Sci/R&D Officer	65	-
Patrick Klein ADM	Chief Administrative Officer	-	22-04-30
Werner Kroll CTO	Chief Tech/Sci/R&D Officer	67	-
Michelle Hodges LAW	General Counsel	-	20-11-30

Members of the board	Title	Age	Since
Kenneth Widder BRD	Director/Board Member	71	13-12-31
Kenneth Buechler CHM	Chairman	70	-
Mary Polan BRD	Director/Board Member	80	92-12-31
Ann Rhoads BRD	Director/Board Member	58	19-12-31
Matthew Strobeck BRD	Director/Board Member	51	17-12-31
Edward Michael BRD	Director/Board Member	66	17-12-31
Evelyn Dilsaver BRD	Director/Board Member	68	21-12-31
Robert Schmidt BRD	Director/Board Member	41	21-12-31
Joseph Wilkins BRD	Director/Board Member	62	20-12-31
James Prutow BRD	Director/Board Member	55	Nov. 27

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	66,878,683	53,476,708 ( 79.96 %)	0	79.96 %

Name	Equities	%	Valuation
The Carlyle Group LP (Global Private Equity) 18.64 %	12,460,183	18.64 %	597 M $
T. Rowe Price Investment Management, Inc. 13.01 %	8,698,143	13.01 %	417 M $
Vanguard Fiduciary Trust Co. 7.242 %	4,841,410	7.242 %	232 M $
BlackRock Advisors LLC 6.777 %	4,530,312	6.777 %	217 M $
Senvest Management LLC 4.487 %	2,999,353	4.487 %	144 M $
ArrowMark Colorado Holdings LLC 3.984 %	2,663,606	3.984 %	128 M $
STATE STREET CORPORATION 2.290 %	1,530,817	2.290 %	73 M $
JPMorgan Investment Management, Inc. 1.997 %	1,335,012	1.997 %	64 M $
Burgundy Asset Management Ltd. 1.737 %	1,161,485	1.737 %	56 M $
Grant Thornton International Ltd. 1.699 %	1,135,898	1.699 %	54 M $

QuidelOrtho Corp.

9975 Summers Ridge Road

92121, San Diego

+858 552 1100

http://www.quidelortho.com

Name	Category and Sector
Quidel Corp. Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.	Medical Specialties
Ortho-Clinical Diagnostics, Inc. Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.	Medical Specialties

Name

Category and Sector

Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

39.69 USD

Average target price

54.73 USD

Spread / Average Target

+37.90%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-46.15%	2.65B
SARTORIUS AG	-13.39%	18.55B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+14.09%	1.81B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.39%	1.61B
BIOTAGE AB	+21.39%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.58%	1.03B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.72%	896M
REVENIO GROUP OYJ	-7.73%	680M
VAREX IMAGING CORPORATION	-17.56%	686M
PHC CO.,LTD.	-.--%	302M

Medical Diagnostic & Testing Equipment